Efficacy and Safety of AZD1222, BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2

Efficacy and Safety of AZD1222, BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2

SARS-CoV-2, the beta coronavirus causing COVID-19, was isolated and categorizes as a novel one on January 7th, 2020 in China.[1] To date, official reports depict that SARS-CoV-2 has already infected 88.828.387 persons and caused 1.926.625 deaths worldwide.[2] On January 12th, 2020, China officials...

Full description

Bibliographic Details
Main Author: Ilir Alimehmeti
Format: Article
Language:English
Published: Albanian Society for Trauma and Emergency Surgery 2021-01-01
Series:Albanian Journal of Trauma and Emergency Surgery
Subjects:
COVID-19
SARS-CoV-2
vaccination
review
clinical trials
Online Access:https://journal.astes.org.al/index.php/AJTES/article/view/178

Similar Items

Similar Items